Skip to main content

Table 4 Drugs used by participants and relevant lab results

From: Prevalence and associated factors of undiagnosed atrial fibrillation among end-stage renal disease patients on maintenance haemodialysis: a cross-sectional study

Variables

Total N = 231 (100.0%)

AF N = 18 (7.8%)

No AF N = 213 (92.2%)

p-value

Omeprazole, Yes (%)

79 (34.2)

4 (22.2)

75 (35.2)

0.392

Lansoprazole, Yes (%)

75 (32.5)

6 (33.3)

69 (32.4)

0.935

Beta-blocker, Yes (%)

94 (40.7)

5 (27.8)

89 (41.8)

0.362

Calcium channel blocker, Yes (%)

100 (43.3)

4 (22.2)

96 (45.1)

0.102

ACE inhibitor, Yes (%)

10 (4.3)

1 (5.6)

9 (4.2)

0.790

Furosemide, Yes (%)

53 (22.9)

4 (22.2)

49 (23.0)

0.940

Calcium carbonate, Yes (%)

209 (90.5)

16 (88.9)

193 (90.6)

0.811

Vitamin D, Yes (%)

26 (11.3)

4 (22.2)

22 (10.3)

0.252

Erythropoietin, Yes (%)

77 (33.3)

6 (33.3)

71 (33.3)

1.000

Alpha 1 hydroxylase vit D, Yes (%)

163 (70.6)

15 (83.3)

148 (69.5)

0.333

Labs

Low haemoglobin (anaemia), Yes (%)

21 (9.1)

1 (5.6)

20 (9.4)

0.891

Serum Ca2+, Low (%)

76 (32.9)

6 (33.3)

70 (32.9)

0.922

Serum K+, Low (%)

7 (3.0)

2 (11.1)

5 (2.4)

0.223

Hypoalbuminemia, Yes (%)

34 (14.7)

2 (11.1)

32 (15.0)

0.885

  1. AF = atrial fibrillation; ACE = Angiotensin converting enzyme